Literature DB >> 22261152

Unexpected result of Hendra virus outbreaks for veterinarians, Queensland, Australia.

Diana H Mendez1, Jenni Judd, Rick Speare.   

Abstract

A qualitative study of equine veterinarians and allied staff from Queensland, Australia, showed that veterinarians are ceasing equine practice because of fears related to Hendra virus. Their decisions were motivated by personal safety and legal liability concerns.

Entities:  

Mesh:

Year:  2012        PMID: 22261152      PMCID: PMC3310112          DOI: 10.3201/eid1801.111006

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


In the mid-1990s, Hendra virus (HeV) emerged as a new pathogen that spilled over from bats to horses to humans (,). All 7 cases of HeV infection among humans in Australia occurred in Queensland. Five of these cases involved equine veterinary personnel who conducted routine necropsies or endoscopies; 3 of the 5 cases were fatal (–). In Australia, equine clinical services are mostly delivered by veterinarians working in private practice. The 3 deaths prompted government and veterinary professional agencies to promote the overhaul of infection-control measures in veterinary practice (,) and increase auditing of veterinary infection-control strategies in private equine practice by Workplace Health and Safety Queensland (). In 2011, HeV outbreaks multiplied throughout Queensland and New South Wales, and samples from a dog were positive for HeV (,). With the approval of the James Cook University Human Ethics Committee (permit H3513), we interviewed veterinarians and allied staff from veterinary practices with the aim of capturing the HeV-related infection-control and workplace health and safety issues faced by equine practices. We report on 1 unexpected emerging issue: the departure of veterinarians from equine practice as a result of HeV outbreaks.

The Study

During 2009–2010, we conducted face-to-face, in-depth interviews with 21 veterinarians and allied staff from 14 equine and mixed private veterinary practices from a range of urban and rural areas between Cairns and Brisbane, Queensland, Australia (Table 1) (). We asked a series of open-ended questions to determine what HeV-related infection-control and workplace health and safety issues confront equine practices (Table 2). Interviews were recorded, transcribed, and analyzed for themes.
Table 1

Location of participants in a study of Hendra virus–related safety issues faced by equine practices, Queensland, Australia, 2009–2010*

Zone, categoryNo. (%) participants
Metropolitan zone
Capital cities3 (14.30)
Population >100,0006 (28.55)
Rural zone
Population 25,000–99,9996 (28.55)
Population 10,000–24,9990
Population <10,0003 (14.30)
Remote zone
Population >4,9993 (14.30)
Population <5,0000

*Location zones and categories are according to the Australian Rural, Remote and Metropolitan Areas classification system ().

Table 2

Demographic characteristic of participants in a study of Hendra virus–related safety issues faced by equine practitioners, Queensland, Australia, 2009–2010

Study participantsNo. (%)Age, y (range)*Years since graduation* (range)†% Time spent doing equine work* (range)‡Distribution by job title, no. (%)
Principal veterinarianPartner/associate or employee veterinarianVeterinary nursePractice manager
Female8 (38.1)35.8 (31–48)13.1 (4–27)30.4 (2–95)§1 (4.8)5 (23.8)2 (9.5)0
Male13 (61.9)48.5 (28–63)22.9 (4–40)52.1 (2–100)¶9 (42.8)3 (14.3)01 (4.8)
Total21 (100.0)42.2 (28–63)19.0 (4–40)47.3 (2–100)10 (47.6)8 (38.1)2 (9.5)1 (4.8)

*Average.
†The practice manager interviewed was not a veterinarian and did not wish to supply this information.
‡Self-reported.
§One female participant did not provide this information.
¶The 1 participant who was a practice manager but not a veterinarian had not spent any time with animals and therefore was not included.

*Location zones and categories are according to the Australian Rural, Remote and Metropolitan Areas classification system (). *Average.
†The practice manager interviewed was not a veterinarian and did not wish to supply this information.
‡Self-reported.
§One female participant did not provide this information.
¶The 1 participant who was a practice manager but not a veterinarian had not spent any time with animals and therefore was not included. Of the 20 veterinary professionals interviewed, 12 (60%) had dealt with >1 suspected cases of HeV, and 7 (35%) had dealt with a confirmed case of HeV. Of the 18 veterinarians interviewed, 4 (22%) reported having ceased equine practice, and as many as 8 (44%) knew of >1 colleagues who had done so in the previous 12 months. The decisions to quit were mostly motivated by the HeV-related fear for personal safety and legal liability. Under the current Queensland legislation governing private businesses, private veterinarians are responsible for the safety of all persons in their workplace, both in the clinic and the field (). Ten (47.6%) of the study participants were principal veterinarians (Table 1) who carried the highest degree of legal responsibility within their veterinary practice; they were quite concerned about their HeV-related legal liability. Four of these principal veterinarians reported ceasing equine practice because of the difficulty in enforcing infection control–related workplace health and safety compliance among their staff, because the logistical outlay of bringing change to their practice was too costly, or both. One participant declared, “The HeV situation was the last straw that made us stop equine practice…. We put it in the too hard basket.” Their fear of prosecution became too big a threat for their business. However, ceasing this high-risk activity does not result in improved infection-control standards. Principal veterinarians from other practices preferred to personally deal with all equine patients, thus taking the highest risk themselves rather than putting their staff at risk or not providing the service. In some instances, staff and principal veterinarians resorted to working in suboptimal personal safety conditions to fulfill their legal and ethical responsibility to their patients and clients, thus jeopardizing the legal situation. As one participant pointed out, “Veterinarians usually end up with less authority… taking the risk out of concern for the welfare of the horse.” Veterinarians have a legal right to refuse service if safety is compromised; however, this would mean forfeiting immediate and future income through the loss of a client(s) and, possibly, reputation. In such instances, the staff and the business remain safe, but the principal veterinarian may not, and the overall standards of infection control within the practice do not improve. Up to 6 (60%) of the interviewed principal veterinarians had embraced the need for improvement of infection-control practices and had made major changes to their protocols and premises, but they felt that the best level of compliance would not be legally protective because of the unpredictable character of the veterinary work environment. Another participant expressed concern over this legal uncertainty: “You still have to worry about what might occur out of the blue…. With workplace health and safety we are very aware that complying is often not enough if an incident occurs.” In this scenario, although safety improvement is achieved, the legal risk remains. Those participants still in equine practice also expressed concern over the consequences that the loss of skilled equine veterinarians would have on the profession and their practice. One participant said, “… this might introduce problems of gaps in the welfare of animals. Vets will need to refer animals.” The lack of equine specialists would increase demands on the remaining equine veterinarians, who would have to further extend their already overstretched time and resources: they would work longer hours, travel farther to provide services, and be unable to reach sick horses in remote locations or to have them tested in a timely fashion. Participants still in equine practice considered that all these factors made working with horses less safe. Indeed, several studies showed that across a wide range of sectors, working >60 hours/week increased the risks for occupational injury and illness (–). Furthermore, several study participants reported that some colleagues now choose to only provide services to healthy animals and refuse to treat sick horses. A participant described this as choosing the “easy safe money” over the “hard dangerous money.” This choice was creating resentment among members of an otherwise tight-knit veterinary community. Over time, resentment could jeopardize professional networking, which seems to play an essential role in disseminating clinical and safety information among veterinarians. Although this study did not measure the overall effect of the decreased number of veterinarians who treat equids in Queensland, participants viewed the decrease as a major source of increased occupational risk for the remaining equine practitioners. If this trend is sustained, more private veterinarians may cease equine practice. Other participants no longer regarded themselves as equine practitioners and declared that they had ceased equine practice; however, they later admitted to still regularly treating horses. Their “official” departure from equine practice would increase their safety and legal risks because they might miss program updates on equine health information or infection-control improvement. It is also possible that the perception of increased risk may adversely influence the decision by younger veterinarians to pursue work in equine practice, thereby jeopardizing the normal replacement of the existing pool of aging equine practitioners. One parallel was the effect of severe acute respiratory syndrome. Overall, 35% of severe acute respiratory syndrome–related deaths were in health care workers. Some workers refused to go to work and others adopted a heroic stance and continued to work, resulting in substantial medium-term psychological effects on the healthcare professionals ().

Conclusions

HeV remains a threat to the veterinary profession and public health in Australia. The experimental success of an HeV vaccine for horses was recently announced; if a vaccine becomes available, it may re-instill confidence in existing and future equine practitioners (). However, the potential that emerging infectious diseases might dismantle the veterinary workforce should be considered when developing official strategies for the management of HeV outbreaks. Infection-control management guidelines and workplace health and safety regulations must consider the context in which services are feasibly delivered to the public and should be devised in consultation with the private veterinary professionals on the frontline of outbreaks.
  10 in total

1.  Extended work hours and risk of acute occupational injury: A case-crossover study of workers in manufacturing.

Authors:  S Vegso; L Cantley; M Slade; O Taiwo; K Sircar; P Rabinowitz; M Fiellin; M B Russi; M R Cullen
Journal:  Am J Ind Med       Date:  2007-08       Impact factor: 2.214

2.  Hendra virus.

Authors:  Jeannette R Young; Christine E Selvey; Rick Symons
Journal:  Med J Aust       Date:  2011-09-05       Impact factor: 7.738

Review 3.  SARS plague: duty of care or medical heroism?

Authors:  Dessmon Y H Tai
Journal:  Ann Acad Med Singapore       Date:  2006-05       Impact factor: 2.473

4.  Fatal encephalitis due to novel paramyxovirus transmitted from horses.

Authors:  J D O'Sullivan; A M Allworth; D L Paterson; T M Snow; R Boots; L J Gleeson; A R Gould; A D Hyatt; J Bradfield
Journal:  Lancet       Date:  1997-01-11       Impact factor: 79.321

5.  A novel morbillivirus pneumonia of horses and its transmission to humans.

Authors:  K Murray; R Rogers; L Selvey; P Selleck; A Hyatt; A Gould; L Gleeson; P Hooper; H Westbury
Journal:  Emerg Infect Dis       Date:  1995 Jan-Mar       Impact factor: 6.883

6.  The impact of overtime and long work hours on occupational injuries and illnesses: new evidence from the United States.

Authors:  A E Dembe; J B Erickson; R G Delbos; S M Banks
Journal:  Occup Environ Med       Date:  2005-09       Impact factor: 4.402

7.  Long working hours increase the risk of sharp and needlestick injury in nurses: the need for new policy implication.

Authors:  Mustafa N Ilhan; Elif Durukan; Evin Aras; Sertaç Türkçüoğlu; Remzi Aygün
Journal:  J Adv Nurs       Date:  2006-12       Impact factor: 3.187

8.  Hendra virus outbreak with novel clinical features, Australia.

Authors:  Hume Field; Kylie Schaaf; Nina Kung; Craig Simon; David Waltisbuhl; Heather Hobert; Frederick Moore; Deborah Middleton; Allison Crook; Greg Smith; Peter Daniels; Ron Glanville; David Lovell
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

9.  Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008.

Authors:  Elliott G Playford; Brad McCall; Greg Smith; Vicki Slinko; George Allen; Ina Smith; Frederick Moore; Carmel Taylor; Yu Hsin Kung; Hume Field
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

10.  Hendra virus infection in a veterinarian.

Authors:  Jeffrey N Hanna; William J McBride; Dianne L Brookes; Jack Shield; Carmel T Taylor; Ina L Smith; Scott B Craig; Greg A Smith
Journal:  Med J Aust       Date:  2006-11-20       Impact factor: 7.738

  10 in total
  19 in total

1.  A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.

Authors:  Katharine N Bossart; Barry Rockx; Friederike Feldmann; Doug Brining; Dana Scott; Rachel LaCasse; Joan B Geisbert; Yan-Ru Feng; Yee-Peng Chan; Andrew C Hickey; Christopher C Broder; Heinz Feldmann; Thomas W Geisbert
Journal:  Sci Transl Med       Date:  2012-08-08       Impact factor: 17.956

2.  A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.

Authors:  Chad E Mire; Joan B Geisbert; Krystle N Agans; Yan-Ru Feng; Karla A Fenton; Katharine N Bossart; Lianying Yan; Yee-Peng Chan; Christopher C Broder; Thomas W Geisbert
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 3.  Hendra virus.

Authors:  Deborah Middleton
Journal:  Vet Clin North Am Equine Pract       Date:  2014-09-30       Impact factor: 1.792

4.  Novel Henipa-like virus, Mojiang Paramyxovirus, in rats, China, 2012.

Authors:  Zhiqiang Wu; Li Yang; Fan Yang; Xianwen Ren; Jinyong Jiang; Jie Dong; Lilian Sun; Yafang Zhu; Hongning Zhou; Qi Jin
Journal:  Emerg Infect Dis       Date:  2014-06       Impact factor: 6.883

5.  Discovery of a Novel Bat Gammaherpesvirus.

Authors:  Kurtis M Host; Blossom Damania
Journal:  mSphere       Date:  2016-02-17       Impact factor: 4.389

6.  Playing with fire - What is influencing horse owners' decisions to not vaccinate their horses against deadly Hendra virus infection?

Authors:  Kailiea Arianna Goyen; John David Wright; Alexandra Cunneen; Joerg Henning
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

7.  Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health.

Authors:  Deborah Middleton; Jackie Pallister; Reuben Klein; Yan-Ru Feng; Jessica Haining; Rachel Arkinstall; Leah Frazer; Jin-An Huang; Nigel Edwards; Mark Wareing; Martin Elhay; Zia Hashmi; John Bingham; Manabu Yamada; Dayna Johnson; John White; Adam Foord; Hans G Heine; Glenn A Marsh; Christopher C Broder; Lin-Fa Wang
Journal:  Emerg Infect Dis       Date:  2014-03       Impact factor: 6.883

8.  Management of the slowly emerging zoonosis, Hendra virus, by private veterinarians in Queensland, Australia: a qualitative study.

Authors:  Diana H Mendez; Jenny Kelly; Petra Buttner; Madeleine Nowak; Rick Speare
Journal:  BMC Vet Res       Date:  2014-09-17       Impact factor: 2.741

9.  Disease Risk Perception and Safety Practices: A Survey of Australian Flying Fox Rehabilitators.

Authors:  Cecilia A Sánchez; Michelle L Baker
Journal:  PLoS Negl Trop Dis       Date:  2016-02-01

10.  Protection from Hendra virus infection with Canarypox recombinant vaccine.

Authors:  Vanessa Guillaume-Vasselin; Laurent Lemaitre; Kévin P Dhondt; Laurence Tedeschi; Amelie Poulard; Catherine Charreyre; Branka Horvat
Journal:  NPJ Vaccines       Date:  2016-07-28       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.